• About
  • Subscribe
  • Advertise
  • Contact
Wednesday, July 15, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

Vision Australia supports acoustic alerting systems for electric vehicles

by rhiannon bowman
June 13, 2023
in Local, News
Reading Time: 3 mins read
A A
When travelling at low speeds, electric vehicles can be hard for pedestrians to hear.

When travelling at low speeds, electric vehicles can be hard for pedestrians to hear.

Share on FacebookShare on Twitter

Not-for-profit organisation Vision Australia has made a submission to a federal government public consultation supporting the proposed introduction of an Acoustic Vehicle Alerting System (AVAS) to electric vehicles.

It also encouraged Australians who are blind or have low vision to share their views with government to improve safety of electric cars, including any experiences they may have had as pedestrians, such as near misses or collisions.

The consultation, which closed on 26 May, will help decide whether alerting systems for electric vehicles should be mandated in Australia, and when.

Vision Australia said when travelling at low speeds electric vehicles can be hard for pedestrians to hear, proving very risky for the blind and low vision community.

“The Australian Government is deciding whether to make it mandatory for electric vehicles to be fitted with an Acoustic Vehicle Alerting System (AVAS) to make it easier for pedestrians to detect them,” it said.

“Specifically, they are determining whether to adopt United Nations Regulation 138/01 as a new Australian Design Rule in electric cars. If mandated, the AVAS could save lives and avoid thousands of injuries.”

According to the Department of Infrastructure, Transport, Regional Development, Communications and the Arts, which is managing the consultation process, electric vehicles generate considerably less noise when compared with vehicles with conventional internal combustion engines.

“At low speeds, when tyre and wind noise is negligible, it can be harder for pedestrians to hear electric vehicles, increasing the risk of a collision. These collisions can still cause serious injury and death. The risk is exacerbated for pedestrians who are blind or have poor vision, as they generally rely on sound to negotiate the road network independently,” it said.

“Through the National Road Safety Action Plan 2023-25, the Australian Government has committed to mandating AVAS for electric vehicles, subject to the outcomes of an impact analysis process.”

The government’s Consultation Impact Analysis sought feedback on:

  • support for the proposed introduction of AVAS for new light electric vehicles in Australia
  • the benefit-cost analysis, including assumptions on the effectiveness of AVAS, the costs and the benefits
  • the suitability of adopting United Nations Regulation 138/01 as a new Australian Design Rule under the Road Vehicle Standards Act 2018, including any concerns on functional and performance and test requirements
  • applicable vehicle categories, implementation timeframes, and alternative standards.

At this stage, the government is proposing to introduce AVAS only for light electric vehicles (vehicle categories MA, MB, MC and NA).

It said while United Nations Regulation 138/01 applies to light and heavy electric vehicles, insufficient data was available to fully assess the case for mandating AVAS for heavy vehicles in Australia. However, it is interested in any information on the costs, benefits and feasibility of mandating AVAS for heavy electric vehicles in the future.

More reading

Silent electric buses pose safety risk to low vision community, NSW inquiry told

Taxi driver left blind by flying rock relies on eye doctor advice in legal stoush

‘Damning’ survey finds employment discrimination rife for low vision Australians

Related Posts

The course will explore the science behind oral medicines. Image: ACO.

ACO: Still time to register for Advanced Ocular Therapeutics course

by Staff Writer
July 15, 2026

With less than two weeks until commencement, the Australian College of Optometry (ACO) is reminding optometrists to secure their place...

The capsule collection draws from Carrera’s historic colours – black, white and red. Image: Carrera.

Carrera celebrates milestone with limited-edition collection

by Rob Mitchell
July 14, 2026

To celebrate its 70th anniversary, Carrera has announced the introduction of an exclusive Made in Italy limited-edition capsule collection that...

Vision Eye Institute CEO Amanda Cranage (right) at Vision Hospital Group’s Boroondara Day Surgery. Images: VEI.

The hidden drivers of cataract success

by Helen Carter
July 14, 2026

It’s not just what happens under the surgical microscope that leads to strong cataract surgery outcomes. Many gains come from...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Products
    • Ophthalmic Treatments
      • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited